Dr. Parks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3960 Lindell Blvd
Saint Louis, MO 63108Phone+1 314-652-0100Fax+1 314-652-0125
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1994 - 1997
Saint Louis University School of MedicineClass of 1994
Certifications & Licensure
MO State Medical License 1995 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013-2014
Clinical Trials
- Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 38 citationsSwitch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.Grace A. McComsey, Sergio Lupo, David A Parks, Mónica Coronado Poggio, Joseph de Wet
AIDS. 2017-12-01 - 6 citationsSteady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen ...David A Parks, H. Clay Jennings, Christopher W Taylor, Gary E. Pakes, Edward P. Acosta
HIV Clinical Trials. 2009-05-01 - 6 citationsPharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects.David A Parks, Harold C Jennings, Christopher W Taylor, Edward P. Acosta
AIDS. 2007-06-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
